EUVIMEDEUVIMED entdecken
Crossref

Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS‐COV ‐2 targeting main protease and papain‐like protease

Shweta Choudhary, Sanketkumar Nehul, Ankur Singh, Prasan Kumar Panda, Pravindra Kumar, Gaurav Kumar Sharma iD, Shailly Tomar iD

IUBMB Life · 2024

DOI: 10.1002/iub.2793 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IUBMB Life, 2024. Verfasst von Shweta Choudhary und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, India. Hauptthemen laut MEDLINE: SARS-CoV-2, Antiviral Agents, COVID-19 Drug Treatment. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Science and Engineering Research Board, Department of Science & Technology, Government of India, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coronavirus disease 2019 (COVID‐19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) may be over, but its variants continue to emerge, and patients with mild symptoms having long COVID is still under investigation. SARS‐CoV‐2 infection leading to elevated cytokine levels and suppressed immune responses set off cytokine storm, fatal systemic inflammation, tissue damage, and multi‐organ failure. Thus, drug molecules targeting the SARS‐CoV‐2 virus‐specific proteins or capable of suppressing the host inflammatory responses to viral infection would provide an effective antiviral therapy against emerging variants of concern. Evolutionarily conserved papain‐like protease (PLpro) and main protease (Mpro) play an indispensable role in the virus life cycle and immune evasion. Direct‐acting antivirals targeting both these viral proteases represent an attractive antiviral strategy that is also expected to reduce viral inflammation. The present study has evaluated the antiviral and anti‐inflammatory potential of natural triterpenoids: azadirachtin, withanolide_A, and isoginkgetin. These molecules inhibit the Mpro and PLpro proteolytic activities with half‐maximal inhibitory concentrations (IC 50 ) values ranging from 1.42 to 32.7 μM. Isothermal titration calorimetry (ITC) analysis validated the binding of these compounds to Mpro and PLpro. As expected, the two compounds, withanolide_A and azadirachtin, exhibit potent anti‐SARS‐CoV‐2 activity in cell‐based assays, with half‐maximum effective concentration (EC 50 ) values of 21.73 and 31.19 μM, respectively. The anti‐inflammatory roles of azadirachtin and withanolide_A when assessed using HEK293T cells, were found to significantly reduce the levels of CXCL10, TNFα, IL6, and IL8 cytokines, which are elevated in severe cases of COVID‐19. Interestingly, azadirachtin and withanolide_A were also found to rescue the decreased type‐I interferon response (IFN‐α1). The results of this study clearly highlight the role of triterpenoids as effective antiviral molecules that target SARS‐CoV‐2‐specific enzymes and also host immune pathways involved in virus‐mediated inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antiviral AgentsCOVID-19 Drug TreatmentHumansTriterpenesCOVID-19Coronavirus 3C ProteasesCoronavirus Papain-Like ProteasesCytokinesMolecular Docking SimulationImmunologic FactorsAnti-Inflammatory Agents

Stichwörter der Autor:innen

MproPLproSARS‐CoV‐2antiviralscytokine stormtriterpenoids

Substanzen

Antiviral AgentsTriterpenesCoronavirus 3C Proteases3C-like proteinase, SARS-CoV-2Coronavirus Papain-Like ProteasesCytokinesImmunologic FactorsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, India.
  • Department of Internal Medicine (Division of Infectious diseases), All India Institute of Medical Sciences (AIIMS), Rishikesh, India.
  • Centre for Animal Disease Research and Diagnosis (CADRAD), Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India.

ORCID-Profile: Gaurav Kumar Sharma, Shailly Tomar

Förderung

  • Science and Engineering Research Board, Department of Science & Technology, Government of India
  • Science and Engineering Research Board

Zitieren

APA

Choudhary, S., Nehul, S., Singh, A., Panda, P. K., Kumar, P., Sharma, G. K., & Tomar, S. (2024). Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS‐COV ‐2 targeting main protease and papain‐like protease. IUBMB Life. https://doi.org/10.1002/iub.2793

Vancouver

Choudhary S, Nehul S, Singh A, Panda PK, Kumar P, Sharma GK, et al. Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS‐COV ‐2 targeting main protease and papain‐like protease. IUBMB Life. 2024. doi:10.1002/iub.2793

BibTeX
@article{Choudhary2024,
  author = {Choudhary, Shweta and Nehul, Sanketkumar and Singh, Ankur and Panda, Prasan Kumar and Kumar, Pravindra and Sharma, Gaurav Kumar and Tomar, Shailly},
  title = {Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS‐COV ‐2 targeting main protease and papain‐like protease},
  journal = {IUBMB Life},
  year = {2024},
  doi = {10.1002/iub.2793}
}
Kostenlos starten →